Back to Browse Journals » Biologics: Targets and Therapy » Volume 2 » Issue 4

The insulin-like growth factor system and its receptors: A potential novel anticancer target

Authors Colin R. Lindsay, T R Jeffry Evans

Published 5 December 2008 Volume 2008:2(4) Pages 855—864


Review by Single-blind

Peer reviewer comments 3

Colin R. Lindsay1, T R Jeffry Evans1,2

1Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom; 2University of Glasgow, CR-UK Beatson Laboratories, Garscube Estate, Glasgow, United Kingdom

Abstract: The current generation of novel anticancer therapies that are in preclinical and clinical development are based on exploiting our increasing understanding of the molecular and cellular basis of cancer development and progression. Accelerated rates of cell division and proliferation have been postulated to predispose to the development of malignant disease. The insulin-like growth factor (IGF) signaling system has an important physiological role in regulating cellular proliferation and apoptosis. This function has led to considerable interest in its relevance to neoplasia over the last decade. In this review, we give an overview of the IGF system physiology, discuss the epidemiological significance of IGF signaling and neoplasia, and review the preclinical and clinical studies in targeting IGF receptors as cancer therapies.

Keywords: insulin, growth factor, IGF-1, clinical trials

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 


Readers of this article also read:

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients

Porpodis K, Domvri K, Zarogoulidis P, Petridis D, Tsirgogianni K, Papaioannou A, Hatzizisi O, Kioumis I, Liaka A, Kikidaki V, Lampaki S, Organtzis J, Zarogoulidis K

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1123-1128

Published Date: 15 June 2015

Focus group reflections on the current and future state of cognitive assessment tools in geriatric health care

Whitehead JC, Gambino SA, Richter JD, Ryan JD

Neuropsychiatric Disease and Treatment 2015, 11:1455-1466

Published Date: 12 June 2015

Development of an oral push–pull osmotic pump of fenofibrate-loaded mesoporous silica nanoparticles

Zhao Z, Wu C, Zhao Y, Hao Y, Liu Y, Zhao W

International Journal of Nanomedicine 2015, 10:1691-1701

Published Date: 3 March 2015

Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM

Neuropsychiatric Disease and Treatment 2014, 10:391-401

Published Date: 21 February 2014

What’s in the pipeline? Drugs in development for autism spectrum disorder

Sung M, Chin CH, Lim CG, Liew HSA, Lim CS, Kashala E, Weng SJ

Neuropsychiatric Disease and Treatment 2014, 10:371-381

Published Date: 20 February 2014

Global decline in semen quality: ignoring the developing world introduces selection bias

Deonandan R, Jaleel M

International Journal of General Medicine 2012, 5:303-306

Published Date: 22 March 2012

Visualization of interaction between inorganic nanoparticles and bacteria or fungi

André Chwalibog, Ewa Sawosz, Anna Hotowy, et al

International Journal of Nanomedicine 2010, 5:1085-1094

Published Date: 6 December 2010

L-Tyrosine-loaded nanoparticles increase the antitumoral activity of direct electric current in a metastatic melanoma cell model

Vânia Emerich Bucco de Campos, Cesar Augusto Antunes Teixeira, Venicio Feo da Veiga, et al

International Journal of Nanomedicine 2010, 5:961-971

Published Date: 15 November 2010

Modeling the economic impact of medication adherence in type 2 diabetes: a theoretical approach

David S Cobden, Louis W Niessen, Frans FH Rutten, et al

Patient Preference and Adherence 2010, 4:283-290

Published Date: 10 August 2010

Ferromagnetic resonance for the quantification of superparamagnetic iron oxide nanoparticles in biological materials

Lionel F Gamarra, Antonio J daCosta-Filho, Javier B Mamani, et al

International Journal of Nanomedicine 2010, 5:203-211

Published Date: 25 March 2010